NLRP3 Inflammasome as a Potentially New Therapeutic Target of Mesenchymal Stem Cells and Their Exosomes in the Treatment of Inflammatory Eye Diseases.

Harrell, Carl Randall; Djonov, Valentin; Antonijevic, Ana; Volarevic, Vladislav

Harrell, Carl Randall; Djonov, Valentin; Antonijevic, Ana; Volarevic, Vladislav.

Afiliação

Harrell CR; Regenerative Processing Plant, LLC, 34176 US Highway 19 N, Palm Harbor, FL 34684, USA.
Djonov V; Institute of Anatomy, University of Bern, Baltzerstrasse 2, 3012 Bern, Switzerland.
Antonijevic A; Center for Harm Reduction of Biological and Chemical Hazards, Faculty of Medical Sciences, University of Kragujevac, 69 Svetozar Markovic Street, 34000 Kragujevac, Serbia.
Volarevic V; Center for Harm Reduction of Biological and Chemical Hazards, Faculty of Medical Sciences, University of Kragujevac, 69 Svetozar Markovic Street, 34000 Kragujevac, Serbia.

Cells ; 12(18)2023 09 21.

Article em En | MEDLINE | ID: mdl-37759549

Assuntos

Exossomos; Oftalmopatias; Células-Tronco Mesenquimais; Humanos; Inflamassomos; Proteína 3 que Contém Domínio de Pirina da Família NLR; Oftalmopatias/terapia

Palavras-chave

NLRP3 inflammasome; exosomes; inflammatory eye diseases; mesenchymal stem cell; therapy

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Oftalmopatias / Exossomos / Células-Tronco Mesenquimais Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google